Loading insider details...
Beta
Latest Form 4 (Apr 20, 2026): Purchase of 3,250,000 SCLX shares, $499.9K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Apr 20, 2026 | Scilex Holding Co (SCLX) | Purchase | 3,250,000 | $499.9K |
| Oct 9, 2025 | Scilex Holding Co (SCLX) | Grant/Award | 120,000 | n/a |
| Oct 31, 2024 | Scilex Holding Co (SCLX) | Purchase | 8,888 | $8.4K |
| Oct 18, 2024 | Scilex Holding Co (SCLX) | Purchase | 10,000 | $9.7K |
| Jun 19, 2024 | Scilex Holding Co (SCLX) | Exercise/Conversion | 6,000 | $8.5K |
| May 17, 2024 | Scilex Holding Co (SCLX) | Purchase | 50,000 | $44.0K |
| Oct 6, 2023 | Scilex Holding Co (SCLX) | Grant/Award | 200,000 | n/a |
| Mar 20, 2023 | Sorrento Therapeutics, Inc. (SRNEQ) | In-the-Money Exercise | 19,500 | $15.7K |
| Mar 20, 2023 | Scilex Holding Co (SCLX) | Other (see footnotes) | 2,730 | $23.5K |
| Jan 17, 2023 | Scilex Holding Co (SCLX) | Grant/Award | 9,000,000 | n/a |